About Arouse Pharma
Arouse Pharma is a Healthcare company. It operates as a pharmaceutical manufacturing and RD services focused on APIs and intermediates in Hyderabad. The company has 11 employees. Its Indian entity Arouse Pharma Private Limited reported revenue of ₹5.29 Cr. Arouse Pharma offers products and services including APIs and Intermediates. Its focus areas include Pharmaceuticals, Research Services, Contract Manufacturing and Custom Synthesis.
Company details
Arouse Pharma Private Limited is recognized as a start-up pharmaceutical company based in Hyderabad, promoted by a group of talented scientists. Innovative research and development is emphasized as the core strength, with customers placed at the center and employees positioned at the forefront. Expertise in developing cost-effective synthetic processes for APIs and intermediates is noted for commercial and clinical applications. A vision is outlined to deliver high-quality affordable life-saving medicines through integrated approaches of scope, expertise, and resources, while a mission is established to become a hub for pharmaceutical development driven by innovation and excellence. (72 words)
- Employees 11
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Arouse Pharma Private Limited
- Date of Incorporation 13 Jun, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹5.29 Cr
FY 2022 · +70% YoY
- Net Profit₹14.5 Lakh
FY 2022 · 3% margin
- EBITDA₹34.2 Lakh
FY 2022 · 6% margin
- Employee Count11
Associated legal entities of Arouse Pharma
Arouse Pharma operates through Arouse Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Arouse Pharma Private Limited CIN U74999TG2018PTC125086 | Active | 13 Jun 2018 | Hyderabad, Telangana | ₹5.3 Cr | 11 | 2 | View details |
Products & Services of Arouse Pharma
Arouse Pharma offers a comprehensive portfolio of products and services, including APIs and Intermediates.
APIs are manufactured for therapeutic classes including anticancer and antidiabetic drugs, with processes optimized for commercial and clinical use.
Intermediates are developed and supplied for drug substances, supporting both regulated and emerging markets through cost-effective synthetic methods.
Board of directors of Arouse Pharma Private Limited (Arouse Pharma)
Arouse Pharma Private Limited is the primary company behind Arouse Pharma. The board of Arouse Pharma Private Limited currently have 2 directors; the longest-serving is Rajesh Kumar Rapolu, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajesh Kumar Rapolu DIN 08538170 | Director | 16 Aug 2019 | 7 yrs 2 mo | Arouse Pharma Private Limited |
| Saraswathi Uddaraju DIN 09595115 | Director | 06 May 2022 | 4 yrs 5 mo | Arouse Pharma Private Limited |
Financials of Arouse Pharma
Figures of Arouse Pharma Private Limited, the primary company behind Arouse Pharma, for FY 2022. Revenue was ₹5.29 Cr (+70% year on year). Net profit was ₹14.5 Lakh (3% margin). EBITDA was ₹34.2 Lakh (6% margin).
- ₹5.29 CrRevenue · FY 2022 · +70% YoY
- ₹14.5 LakhNet profit · 3% margin
- ₹34.2 LakhEBITDA · 6% margin
- ₹40 LakhPaid-up capital
- 11Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Arouse Pharma Private Limited are on its company page.
Detailed financial statements for Arouse Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Arouse Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Arouse Pharma
Arouse Pharma has 11 employees.
The primary company behind Arouse Pharma, Arouse Pharma Private Limited, reported revenue of ₹5.29 Cr for FY 2022, up 70% year on year.
Arouse Pharma Private Limited is recognized as a start-up pharmaceutical company based in Hyderabad, promoted by a group of talented scientists. Innovative research and development is emphasized as the core strength, with customers placed at the center and employees positioned at the forefront. Expertise in developing cost-effective synthetic processes for APIs and intermediates is noted for commercial and clinical applications. A vision is outlined to deliver high-quality affordable life-saving medicines through integrated approaches of scope, expertise, and resources, while a mission is established to become a hub for pharmaceutical development driven by innovation and excellence. (72 words).
Arouse Pharma offers APIs and Intermediates.
Arouse Pharma operates through Arouse Pharma Private Limited.
The legal entities of Arouse Pharma currently have 2 directors, including Saraswathi Uddaraju, Rajesh Kumar Rapolu.